Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action.
Marek
G J
GJ
Department of Psychiatry, Yale University School of Medicine, Ribicoff Research Facilities of the Connecticut Mental Health Center, New Haven 06508, USA. gerard.marek@yale.edu
Aghajanian
G K
GK
D000818:Animals; D001526:Behavioral Symptoms / Q000139:chemically induced; D001921:Brain / Q000187:drug effects*; D004873:Ergolines / Q000737:chemistry / Q000494:pharmacology*; D006213:Hallucinogens / Q000494:pharmacology*; D006801:Humans; D007211:Indoles / Q000737:chemistry / Q000494:pharmacology*; D008125:Locus Coeruleus / Q000187:drug effects; D009044:Motor Cortex / Q000187:drug effects; D019579:Neocortex / Q000187:drug effects; D009431:Neural Conduction / Q000187:drug effects; D010627:Phenethylamines / Q000737:chemistry / Q000494:pharmacology*; D011985:Receptors, Serotonin / Q000187:drug effects*; D012559:Schizophrenia / Q000503:physiopathology; D013569:Synapses / Q000187:drug effects
D004873:Ergolines; D006213:Hallucinogens; D007211:Indoles; D010627:Phenethylamines; D011985:Receptors, Serotonin